Laboratory Diagnostics

Pathology remains fundamental to modern clinical diagnostics, supplying the cellular, tissue, and organ‑level insights that guide disease detection, treatment selection, and patient management. As healthcare becomes more data‑driven and personalized, the value of pathology continues to increase. Advances in imaging, staining, and molecular techniques have improved understanding of how structural changes in tissues relate to…

The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…

The molecular diagnostics market remains a powerful growth engine within the global in vitro diagnostics (IVD) industry. Several years after the pandemic, demand continues to expand across infectious disease testing, cancer diagnostics, and transplant applications. Kalorama Information’s World Market for Molecular Diagnostics, 14th Edition delivers a comprehensive, data-driven analysis of this fast-evolving sector, examining the…

The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.

As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well…

Updated December 2025

Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030,…

In Vitro Diagnostics (IVD) in the United States, 6th Edition provides a comprehensive analysis of the largest and most influential IVD market in the world. This report is an essential resource for companies, manufacturers, executives, marketers, and other key stakeholders seeking actionable insights into the U.S. IVD industry—a market that serves as a global incubator…

Updated December 2025

Kalorama Information’s In Vitro Diagnostic (IVD) Trends and Market Update, 2025 delivers critical insights into the evolving IVD market amid global economic uncertainties. Published twice annually—in April and in December following the release of Kalorama’s flagship study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition—this report serves as both a standalone resource and…

Sepsis remains one of the most urgent and costly challenges in modern healthcare. Characterized by a life-threatening immune response to infection, sepsis affects an estimated 27 million people and causes 5 million deaths worldwide each year, including approximately 2 million cases and 270,000 deaths in the United States alone. Early detection is critical to survival,…

The convenience revolution in healthcare has arrived—and diagnostics are at the center of it. The Global Market for At-Home and Home Collection In Vitro Diagnostic (IVD) Testing, 2025–2030 provides a comprehensive analysis of one of the fastest-evolving sectors of the diagnostics industry. Covering both self-administered over-the-counter (OTC) tests and home collection kits analyzed in central…

The next era of healthcare is here—and it’s powered by companion diagnostics (CDx). These essential tools are redefining how diseases are detected, monitored, and treated by aligning diagnostics directly with therapeutic decision-making. Kalorama Information’s Companion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th Edition provides an in-depth, data-driven analysis of this rapidly evolving market—one…

The global in vitro diagnostics (IVD) market continues to expand in 2025, driven by powerful innovations in next-generation sequencing (NGS), microfluidics, and precision medicine that are transforming diagnostics into a more personalized, patient-centric field. IVD Test Procedure Volumes, 7th Edition (2025-2030) provides a comprehensive, data-driven analysis of global test volume trends, serving as a critical…

Kalorama Information’s Biomarkers in Diagnostics: Global Strategic Insights and Forecasts to 2031 provides a comprehensive analysis of the worldwide clinical diagnostic biomarker market, with forecasts from 2022 through 2031. The report examines diagnostic substances and tests used for disease detection, therapy selection, disease monitoring, and evaluation of treatment effectiveness across seven major product categories: infectious…